Description of COVID-19 patients admitted in an intensive care unit in the Seychelles Islands

Yordanys Paez Candelaria, Ashish Alexander, Sarka Viktorova, Kenneth Henriette, Laura Bernadette Valerie Gayon

Texto completo:

PDF (English)

Resumen

@font-face{ font-family:"Times New Roman"; } @font-face{ font-family:"宋体"; } @font-face{ font-family:"Arno Pro"; } @font-face{ font-family:"Arial"; } p.p0{ margin:0pt; margin-bottom:0,0001pt; margin-bottom:0pt; margin-top:0pt; font-size:10,5000pt; font-family:'Times New Roman'; } p.p15{ margin-bottom:0pt; margin-top:0pt; layout-grid-mode:char; color:rgb(0,0,0); font-size:12,0000pt; font-family:'Arno Pro'; } } div.Section0{page:Section0;}

ntroduction: SARS-CoV-2 has caused thousands of deaths, and was consequently labelled by the World Health Organization (WHO as a pandemic in 2020.Objectives: To describe the population affected by COVID-19 infection, according to selected epidemiological, laboratory and clinical variables; in addition to estimating mortality and length of stay in the population studied. Design, frame of reference and patients: An observational retrospective study was carried out on seriously ill patients diagnosed with COVID-19, who were admitted to the Intensive Care Unit (ICU) of the H.H Sheikh Khalifa Bim Zayed Al Nahyan Hospital in the period from January 2021 to September 2021.Results: During the investigation, it is evident that there was a predominance of patients aged between 45 and 64 years (48.6%), mainly affecting men (56.8%). Most patients were not vaccinated (93.2%), had leukocytosis (75.7%) and normal D-dimer (41.9%). Severe acute respiratory distress syndrome (ARDS) was present in 66.2%. 60.8% of the total patients passed away, amongst which 52.7% of those deceased group had a stay of less than 10 days. Conclusions: The population was comprised of middle-aged, male patients with a history of non-communicable, chronic diseases, unvaccinated, diagnosed mainly with rapid antigen tests. Laboratory studies were fundamental to assess the initial state and clinical evolution, and depicting the severity of the disease leading to high mortality.

Palabras clave

Intensive Care Unit; Acute Respiratory Distress Syndrome; Mechanical ventilation; COVID-19.

Referencias

Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? Rev Arab J Gastroenterol. [online series]. 2020 [cited 2021 Jul 24]; 21(1):3‐8 Available in: http://doi.org/10.1016/j.ajg.2020.03.002

Quintero Marzola ID, Galindo Velásquez HA, Rodríguez Blanco, Quintana Pájaro LJ, Ramos Villegas Y, Yepes IJ, et al. Evidencia de alteraciones gastrointestinales en COVID-19: manifestaciones y teorías en fisiopatología. Rev Colomb Gastroenterol. [online series]. 2020 [cited 2021 Jul 24]; 35(2). Available in: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1126318

Lucas Choez M, Zambrano Cerón D, García Zambrano C, Pincay Pin V. Riesgos y consecuencias de los pacientes contagiados con COVID 19. RECIMUNDO [online series]. (2020) [cited 2021 Aug. 14]; 4(2), 217-225. Available in: http://recimundo.com/index.php/es/article/view/841

Romo DKJ, Saucedo REG, Hinojosa MS, Mercado RJY, Uc RJE, Ochoa GE et al. Manifestaciones clínicas de la COVID-19. Rev Latin Infect Pediatr. [online series]. (2020) [cited 2021 Aug. 14]; 33 (1):10-32. Available in: https://dx.doi.org/10.35366/96668

Cinesi Gómez C, Peñuelas Rodriguez O, Luján Torné M, et al. Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-1. Rev Arch Bronconeumol. [online series]. 2020 [cited 2021 Aug. 14]. Available in: https://es.scribd.com/document/472643953/Recomendaciones-de-consenso-respecto-al-soporte-respiratorio-no-invasivo-en-el-paciente-adulto-con-insuficiencia-respiratoria-aguda-secundaria-a-infec

Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Rev radiology. [online series]. 2020 [cited 2021 Jun 18]. Available in: https://es.scribd.com/document/458457131/2020-COLOMBIA-COVID-19

Albajar Bobes A, Álvarez Bartolomé A, García Fernández J, Angela Herrero Cano, Martínez Jiménez F, et al. Manejo del paciente critico COVID19 en UCI. [online series]. [cited 2021 Jun 18]. Available in: https://www.amazon.es/MANEJO-DEL-PACIENTE-COVID-19 Actualizaci%C3%B3n/dp/B08TZBV34N/ref=sr_1_1?__mk_es_ES=%C3%85M%C3%85%C5%BD%C3%95%C3%91&dchild=1&keywords=uci+covid&qid=1611951464&sr=8-1

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, di Napoli R. Features evaluation and treatment coronavirus (COVID-19). StatPearls. [online series]. 2020 [accessed 1 June 2020]. Available in: http://www.ncbi.nlm.nih.gov/pubmed/32150360

Del Carpio Orantes L, García Méndez S, Contreras-Sánchez ER, González Segovia O, et al. Caracterización clínica y del hemograma de pacientes con neumonía por COVID-19 en Veracruz, México. Rev. Hematol Méx. [online series]. 2020 [cited 2021 Jun 18]; 21 (4): 205-209. Available in: https://doi.org/10.24245/rev_hematolv21i4.4488

Ueyama, Hiroki, et al. “Gender Difference Is Associated with Severity of Coronavirus Disease 2019 Infection: An Insight from a Meta-Analysis.” Critical Care Explorations. [online series]. 2020 [cited 2021 Jun 18]; 2(6). Available in: https://journals.lww.com/ccejournal/Fulltext/2020/06000/Gender_Difference_Is_Associated_With_Severity_of.26.aspx

Gebhard C, et al. “Impact of Sex and Gender on COVID-19 Outcomes in Europe.” Biology of Sex Differences, [online series]. 2020 [cited 2021 Jun 18]; 11(1). Available in: https://pubmed.ncbi.nlm.nih.gov/32450906/

Gadi Nirupa, et al. “What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.” Frontiers in Immunology [ online series]. 2020 [cited 2021 Jun 18]; 11. Available in: https://pubmed.ncbi.nlm.nih.gov/32983176/

Fantin R, Brenes-Camacho G, Barboza-Solís C. Defunciones por COVID-19: distribución por edad y universalidad de la cobertura médica en 22 países. Rev Panam Salud Pública [online series]. 2021[cited 2021 June 28]; 45: (42). Available in: https://doi.org/10.26633/RPSP.2021.42

Plasencia-Urizarri TM, Aguilera-Rodríguez R, Almaguer-Mederos LE. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Rev haban cienc méd [online series]. 2020 [cited 2021 Jun 28]; 19. Available in: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3389

Sánchez Zúñiga MJ, Carrillo Esper R. Coronavirus-2019.Consideraciones Generales. Rev Mex Anestesiol, [online series]. 2020 [cited 2021 Jun 28]; 43 (2): 83-9. Available in: https://dx.doi.org/10.35366/92866

Del Carpio Orantes L, García Méndez S, Contreras-Sánchez ER, González Segovia O, et al. Caracterización clínica y del hemograma de pacientes con neumonía por COVID-19 en Veracruz, México. Rev Hematol Méx. [online series]. 2020 [cited 2021 Jun 28]; 21 (4): 205-209. Available in: https://doi.org/10.24245/rev_hematolv21i4.4488

Organización Mundial de la Salud. Hoja de ruta del SAGE de la OMS para el establecimiento de prioridades en el uso de vacunas contra la COVID-19 en un contexto de suministros limitados. [Internet series]. 2020 [cited 2021 Mar 28]. Available in: https://cdn.who.int/media/docs/default-source/immunization/sage/covid/sageprioritization-roadmapcovid19vaccineses.pdf?sfvrsn=bf227443_36&download=true

Plan Estratégico para la vacunación contra la COVID-19 en Argentina. [ online series]. 2021 [cited 2021 Mar 28]. Available in:https://www.argentina.gob.ar/coronavirus/vacuna/plan-estrategico

Del Carpio Orantes L, García Méndez S, Contreras-Sánchez ER, González Segovia O,et al. Caracterización clínica y del hemograma de pacientes con neumonía por COVID-19 en Veracruz, México. Rev Hematol Méx. [online series]. 2020 [cited 28 Mar. 2021]; 21 (4): 205-209. Available in: https://doi.org/10.24245/rev_hematolv21i4.4488

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Rev Am J Hematol. [online series]. 2020 [cited 28 Mar. 2021]; 95(7):834–47. Available in: https://pubmed.ncbi.nlm.nih.gov/32282949/

Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. [online series]. 2020 [cited 2021 Sep 25];5(1):16-8. Available in: https://pubmed.ncbi.nlm.nih.gov/32296069/

Del Carpio Orantes L, García Méndez S, Contreras Sánchez ER, González Segovia O y col. Caracterización clínica y del hemograma de pacientes con neumonía por COVID-19 en Veracruz, México. Rev Hematol Méx [online series]. 2020 [cited 2021 Sep 25]; 21 (4): 205-209. Available in: https://doi.org/10.24245/rev_hematol.v21i4.448

Nota de prensa, sociedad española de neumología y cirugía de tórax (SEPAR). [online series ]. 2020 [cited 2021 Sep 25]. Available in:

Kariyanna P, Aurora L, Jayarangaiah A, Yadav V, Hossain NA, Akter N, et al. Utility of D-dimer as a prognostic factor in SARS CoV2 infection: Rev Am J Med Case Rep [online series]. 2020 [cited 2021 Sep 25]; 8(10):337–40. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447555/

Moreno G, Carbonell R, Bodí M, Rodríguez A. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Med Intensiva [online series]. 2020 [cited 20 Oct. 2021]; 20 :30187. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298463/

Kariyanna P, Aurora L, Jayarangaiah A, Yadav V, Hossain NA, Akter N, et al. Utility of D-dimer as a prognostic factor in SARS CoV2 infection: A review. Am J Med Case Rep [online series]. 2020 [cited 20 Oct. 2021];8(10):337–40. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447555/

Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID. 19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol [online series]. 2020 [cited 20 Oct. 2021]; 127:104362. Available in: https://www.sciencedirect.com/science/article/abs/pii/S1386653220301049

Kariyanna P, Aurora L, Jayarangaiah A, Yadav V, Hossain NA, Akter N, et al. Utility of D-dimer as a prognostic factor in SARS CoV2 infection: A review. Am J Med Case Rep [online series]. 2020 [cited 20 Oct. 2021];8(10):337–40. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447555/

Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med [online series]. 2020 [cited 20 oct. 2021]; 58(7):1116–20. Available in: https://pubmed.ncbi.nlm.nih.gov/32172226/

Vera Carrasco O. SÍNDROME DE DISTRÉS RESPIRATORIO AGUDO Y COVID-19. Rev Med La Paz. [online series]. 2021 [cited 20 oct. 2021]; 27(1). Available in: http://scielo.org.bo/pdf/rmcmlp/v27n1/v27n1_a10.pdf

Pérez A, Ramos A, Carreras G. Insulin therapy in hospitalized patients. Am J Ther. Rev Diabetes Care [online series]. 2018 [cited 20 oct. 2021]; 27:71-8. Available in: https://pubmed.ncbi.nlm.nih.gov/31833876/

Bellidoa V, Pérez A. Consecuencias de la COVID-19 sobre las personas con diabetes. Rev Endocrinol Diabetes Nutr. [online series]. 2020 [cited 20 Oct 2021];67(6):355-356. Available in: https://doi.org/10.1016/j.endinu.2020.04.001

Cheng Y, Luo R, XuW, KunW, Nanhui Z, Meng Z, ZhixiangW, et al. The incidence, risk factors, and prognosis of acute kidney injury in adult patients with COVID-19. Rev Clin J Am Soc Nephrol. [online series]. 2020 [cited 25 Oct. 2021]; 15: 1394–1402. Available in: https://pubmed.ncbi.nlm.nih.gov/32963018/

Hoste Seminar web ESIC 15 april. Available in: https://www.worldwidejournals.com/global-journal-for-research-analysis-GJRA/recent_issues_pdf/2021/March/renal-lymphangiectasia-in-a-patient-affected-by-covid19_March_2021_0127519765_1414484.pdf

Sieswerda E, de Boer MGJ, Bonten MMJ, et al. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Rev Clin Microbiol Infect. [online series]. 2020 [cited 25 oct. 2021]; (20) 30594-2. Available in: https://pubmed.ncbi.nlm.nih.gov/33010444/

Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Rev Crit Care Med. [online series]. 2017 [cited 25 Oct. 2021];45(3): 486-552. Available in: https://www.ncbi.nlm.nih.gov/pubmed/28098591

Gutiérrez López A, Cruz Cardentey M, Mengana Betancourt A, Castañeda Chirino O, Martínez López F, et al. Arritmias cardíacas en pacientes con la COVID-19. Escenarios y tratamiento. Rev Cuban Cardiol. [online series]. 2020 [cited 25 oct. 2021]; 26(3). Available in: http://www.revcardiologia.sld.cu

Plotnikow GA, Matesa A, Nadur JM, Alonso M, Nuñez I, et al. Características y resultados de los pacientes infectados con CoV19 con requerimiento de ventilación mecánica invasiva en la Argentina. Rev Bras Ter Intensiva. [online series]. 2020 [cited 25 oct. 2021]; 32(3):348-353. Available in: https://www.scielo.br/j/rbti/a/jNXHFBN6NYh3jdwwvGsFndN/?format=pdf

Abarca Rozas B, Vargas Urra J, García Garzón J. Características de la ventilación mecánica invasiva en COVID-19 para médicos no especialistas. Rev Chil Anest. [online series]. 2020 [cited 25 oct. 2021]; 49: 504-513. Available in: https://revistachilenadeanestesia.cl/revchilanestv49n04-06/

Del Carpio Orantes L, García Méndez S, Contreras Sánchez ER, González Segovia O, et al. Caracterización clínica y del hemograma de pacientes con neumonía por COVID-19 en Veracruz, México. Rev Hematol Méx. [online series]. 2020 [cited 25 oct. 2021]; 21 (4): 205-209. Available in: https://doi.org/10.24245/rev_hematol. v21i4.4488

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2024 Panorama. Cuba y Salud

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.